{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:11:58Z","timestamp":1761862318350},"reference-count":0,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T00:00:00Z","timestamp":1068768000000},"content-version":"vor","delay-in-days":2327,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1997,7]]},"abstract":"<jats:p> <jats:italic>Background<\/jats:italic>: Prolonged treatment with omeprazole 20 or 40\u2003mg\/day is sometimes required, especially for severe oesophagitis. However, information about long\u2010term effects on intragastric acidity and plasma gastrin response with such drug regimens is scarce.<\/jats:p><jats:p> <jats:italic>Methods<\/jats:italic>: Sixteen healthy subjects (11 men, 5 women, mean age 29 years) randomly received either 20 or 40\u2003mg of omeprazole once daily (at 08.00\u2003h) for 3 months. Gastric pH was recorded every 6\u2003s for 24\u2003h from noon to noon under standardized conditions, and blood samples were collected hourly in order to determine the 24\u2010h plasma gastrin response on day 0 (pre\u2010entry), day 7, day 28 and day 90.<\/jats:p><jats:p> <jats:italic>Results<\/jats:italic>: From day 0 to day 7, 24\u2010h median pH increased from 1.7 to 4.6 and mean percentage of time at pH\u2003&lt;\u20034 decreased from 89% to 35% with omeprazole 20\u2003mg. Respective values with omeprazole 40\u2003mg were 1.9 to 4.3, and 89% to 34%. Inhibition of gastric acidity remained unchanged during the 3 months of treatment. Despite similar effects on the basis of 24\u2010h analysis, the decrease in daytime acidity was slightly higher with omeprazole 40\u2003mg than with omeprazole 20\u2003mg. Twenty\u2010four\u2010hour integrated plasma gastrin significantly increased with both drug regimens between day 0 and day 7 (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01), and between day 7 and day 28 (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01) with omeprazole 40\u2003mg; there was no significant increase between day 28 and day 90 with either of the drug regimens.<\/jats:p><jats:p> <jats:italic>Conclusion<\/jats:italic>: Omeprazole 20 and 40\u2003mg\/day provides long\u2010term stable acid suppression with a progressive increase in gastrin response, stabilizing after 2 months of treatment.<\/jats:p>","DOI":"10.1046\/j.1365-2036.1997.00182.x","type":"journal-article","created":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T11:43:13Z","timestamp":1068810193000},"page":"747-753","source":"Crossref","is-referenced-by-count":11,"title":["Twenty\u2010four\u2010hour intragastric acidity and plasma gastrin during 3\u2010month treatment with omeprazole in healthy subjects"],"prefix":"10.1111","volume":"11","author":[{"given":"J.\u2010C.","family":"DELCHIER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"BENAMOUZIG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"STANESCU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"ROPERT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"VALLOT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"WIRQUIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"ROUDOT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"LAMARQUE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"HAMELIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,11,14]]},"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1997.00182.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1997.00182.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T03:17:12Z","timestamp":1694402232000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1997.00182.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["10.1046\/j.1365-2036.1997.00182.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1997.00182.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}